484 Development of a Prediction Model for Premalignant and Malignant Pancreatic Cystic Lesions Using Clinical and Endoscopic Ultrasound (EUS) Features: Implications for Risk Stratification

Suboptimal accuracy of carcinoembryonic antigen in differentiation of mucinous and nonmucinous pancreatic cysts: results of a large multicenter study

“…51 The clinical applications of these novel biomarkers are yet to be determined, and it is likely that a successful tool will use more than 1 piece of information for risk stratification. 52 A recent study of 85 patients by Yoon et al 54 showed that the CEA level may vary based on the histologic subtype of IPMN (gastric, intestinal, oncocytic, There are limitations to this study. This study is subject to bias based on its retrospective study design.…”